Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly

NCT04756466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2024-10-21

No results posted yet for this study

Summary

The objective of this trial is to evaluate the effect of the consumption of a probiotic strain on the incidence and severity of COVID-19 in elderly population living in a nursing home. In addition, it will be evaluated if the probiotic strain have some effect on the immune response generated by the Covid-19 vaccine inthis population.

Conditions

  • SARS CoV-2 Infection
  • Elderly

Interventions

DIETARY_SUPPLEMENT

Placebo

Each participant will consume 1 capsule per day in one of the main meals without any restriction in the diet or in their life habits

DIETARY_SUPPLEMENT

Lactobacillus

Each participant will consume 1 capsule per day in one of the main meals without any restriction in the diet or in their life habits

Sponsors & Collaborators

  • Biosearch S.A.

    lead INDUSTRY

Principal Investigators

  • Mónica Olivares, PhD · Biosearch S.A.

  • Anxo Fernandez-Ferreiro, PhD · Complejo Hospitalario Universitario de Santiago Compostela

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-04-30
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04756466 on ClinicalTrials.gov